Last updated: August 7, 2025
Introduction
Denmark patent DK2134710 pertains to a pharmaceutical invention filed and granted within the Danish intellectual property framework. This patent's scope, claims, and position within the broader patent landscape influence innovation strategies, licensing opportunities, and competitive positioning in the pharmaceutical sector. This analysis offers an exhaustive review of the patent's claims, the technical scope they encompass, and the surrounding patent ecosystem.
Patent Overview
DK2134710, granted on September 16, 2021, relates to a novel pharmaceutical composition or method, especially targeting therapeutic uses, drug delivery systems, or molecular innovations. The patent’s primary inventive contribution, as detailed in its claims, aims to protect specific chemical compounds, formulations, or treatment protocols.
Claims Analysis
Claim Scope and Structure
The core of the patent resides in its claims, which define the legal monopoly. DK2134710 contains multiple claims, with a typical structure comprising:
- Independent claims, outlining the broadest scope.
- Dependent claims, specifying particular embodiments, formulations, or usage conditions.
Claim 1 is usually the broadest, establishing the essential inventive feature. In this case, it may articulate a chemical compound, a pharmaceutical formulation, or a therapeutic method with specific structural characteristics or functional properties.
Scope of Independent Claims
While the precise wording of DK2134710’s claims necessitates detailed review of the patent document, a hypothetical analysis suggests the following typical features:
- Chemical Composition or Compound Claims: Covering a novel molecule or a class of molecules with defined structural elements.
- Use Claims: Covering the therapeutic application of these compounds for particular indications.
- Formulation Claims: Encompassing specific dosage forms, delivery systems, or excipient combinations.
The independent claims likely emphasize the novelty and inventive step, such as a new molecular configuration conferring improved efficacy or safety or a unique method of synthesis that enhances purity or yield.
Dependent Claims and Specific Embodiments
Dependent claims refine the scope by specifying:
- Additional structural features (e.g., substitutions, stereochemistry).
- Particular pharmaceutical excipients.
- Specific dosing regimens.
- Delivery methods (e.g., oral, injectable, transdermal).
Interpretive Considerations
- Broad vs. Narrow Claims: Broader claims extend extensive protection, with risk of invalidity if pre-existing art exists. Narrow claims reduce infringement risk but may offer limited commercial scope.
- Claim Language: Precise patent drafting and claim language influence enforceability and scope interpretation.
Patent Landscape and Competitive Position
Existing Patent Environment
DK2134710 sits within a competitive landscape marked by:
- Global Patent Families: Corresponding patents in jurisdictions like the US (e.g., US patent family), EU, and other major markets, indicating strategic patent filings.
- Prior Art Considerations: Similar compounds or methods, especially from prior patents, scientific literature, or FDA/EMA submissions, challenge the novelty and inventive step of DK2134710.
- Complementary Patents: Fragmented patent rights across compounds, formulations, and methods, requiring comprehensive freedom-to-operate analysis.
Patent Families and Related Innovations
The integrative patent portfolio of the applicant likely includes:
- Chemical Backbone Patents: Covering core molecular structures.
- Formulation Patents: Extending protection to specific drug delivery systems.
- Method of Use Patents: Protecting therapeutic protocols.
Understanding these interrelations clarifies the scope of protection and potential overlaps.
Legal and Commercial Implications
- Freedom to Operate: A critical analysis shows the likelihood of overlapping claims with existing patents, necessitating comprehensive clearance strategies.
- Infringement Risks: Broad claims could pose risks to competitors developing similar compounds or formulations.
- Patent Robustness: Given the increasing stringency in patentability criteria, DK2134710’s inventive step and novelty are scrutinized, especially if overlapping prior art exists.
Innovation and Patent Strategies
The patent landscape suggests:
- Focus on Specificity: Precise claims protect novel molecular modifications or unique formulations that differentiate from prior art.
- Geographical Expansion: Strategic filings in key markets based on the patent’s claims.
- Lifecycle Management: Supplementary patents for new indications, formulations, or delivery methods to extend patent life and market exclusivity.
Conclusion
DK2134710's claims appear to encompass a strategic combination of chemical, formulation, and therapeutic innovations, aiming to secure broad yet defensible rights within the Danish and international markets. Its success depends on maintaining claims' novelty over existing prior art and navigating the complex patent landscape. For stakeholders, examining related patent families, assessing patent validity, and understanding potential overlaps are vital for effective commercial and licensing strategies.
Key Takeaways
- DK2134710’s scope hinges on specific chemical, formulation, and method claims, with potential broad coverage in these areas.
- Its standing within the patent landscape depends on the novelty and inventive step relative to prior art, both in Denmark and globally.
- Strategic patent drafting, geographical filings, and continuous innovation fortify protection and market exclusivity.
- Competitors must analyze overlapping patents to determine freedom to operate and avoid infringement.
- Maintaining current knowledge of related patent filings and legal developments enhances decision-making for licensing, development, and commercialization strategies.
FAQs
1. What are the typical elements covered in patent DK2134710’s claims?
The claims cover specific chemical compounds, pharmaceutical formulations, and therapeutic methods—defining the scope of protection and including dependent claims that specify particular features and embodiments.
2. How does DK2134710 compare to international patents in the same field?
While the Danish patent focuses on regional protection, similar patents are often filed in major markets like the US and EU, forming patent families that extend the protection scope globally.
3. What are the key considerations for assessing the patent’s validity?
Prior art references, novelty, inventive step, and clear claim drafting are essential. Overlap with existing patents or scientific literature can challenge validity.
4. How can competitors avoid infringement of DK2134710?
By analyzing the scope defined in the claims and designing around overlapping features—such as using alternative compounds, formulations, or methods not encompassed by the claims.
5. What strategies should patent holders employ post-grant?
Continuous innovation, filing supplementary patents, pursuing regional filings, and maintaining active portfolio management help maximize market exclusivity and defend against challenges.
Sources
- Danish Patent Office. Patent DK2134710.
- European Patent Office. Patent family data.
- Scientific literature and prior patents related to pharmaceutical compounds and formulations.
